Launching Algocyte Proxima at the Royal Society of Medicine in London
Hybrid symposium at the Royal Society of Medicine for the official launch of Proxima, our next-generation haematological analyser.
Read articleMore from us
Algocyte wins 3rd prize at The Next Unicorn Europe
Algocyte placed third at The Next Unicorn Europe in Ibiza, selected from more than 600 startups across the continent.
Learn more
Algocyte expands international research deployment across North America and the Middle East
Following UK research placements, Algocyte enters a new chapter with deployments in the UAE, Mexico and Canada.
Learn more
Algocyte welcomes Dr Pradip Banerjee as new Board Director
Dr Pradip Banerjee, PhD, MBA — CEO and Chairman of Xybion Digital — joins the Algocyte Board of Directors following his investment.
Learn more
'Hospital of the Future' at New Scientist Live 2025 with Algocyte Voted Festival’s Most Popular Feature
We are happy to share that the 'Hospital of the Future' exhibition at New Scientist Live 2025 held in London 2 months ago led by the School of Biomedical Engineering & Imaging Sciences of King's College London where we
Learn more
Oxford Immune Algorithmics® reveals the Future of Blood Testing with Algocyte® at London’s New Scientist Live Festival
OIA’s Founder and KCL’s Associate Professor Dr. Hector Zenil leading the KCL and OIA groups at the New Scientist Live Festival.
Learn more
Avatrial and OIA Announce Partnership: Building Together the Future of Immune Health and Precision Oncology for Drug Discovery
We are pleased to announce that OIA and Avatrial have signed a Memorandum of Understanding to establish a strategic collaboration that brings together two complementary visions: advancing oncology discovery and pioneering AI-enabled immune...
Learn more
Oxford Immune Algorithmics Gains Access to 60 million Anonymised Medical records & Deploys Algocyte® Devices for Testing and Validation with Leading NHS Hospitals in England
London, 31 May 2025 – Oxford Immune Algorithmics® (OIA) , a deep-tech spinout from King’s College London (KCL) and Oxford University , has placed a second Algocyte ® device at an NHS Foundation Trust...
Learn more
Lord Darzi Team Visit OIA to Discuss the Potential of Algocyte to Solve a Human Health Challenge
From left to right: Dr. Hector Zenil, Founder of OIA and Associate Professor at King’s College London; Professor Sebastian Ourselin, Director of LIHE and Head of the School of Biomedical Engineering and Imaging Sciences; Lord Darzi; and his team...
Learn more
University of Harvard group and Dr. Eric Topol's interpretation of new Nature paper validates Algocyte's and OIA's main value proposition
Traditional blood testing often relies on standard reference ranges based on population averages to inform clinicians and patients, but new results on 12,000 adults who received multiple Complete Blood Count tests across 20 years, show that...
Learn more
OIA Founder Dr. Hector Zenil at prestigious industry panel of life science leaders on the future of ageing
Founder of Oxford Immune Algorithimics (OIA) participates in the 73rd Annual Scientific Meeting as one of the trustees of the British Society for Research on Ageing (BSRA) representing King's College London and OIA/Algocyte
Learn more
AI Dialogue with History: How the Past Will Forge Our Future to Transform Healthcare
Welcome to "Dialogue with History: The Future of Healthcare ," an education resource composed of a collection of videos where artificial intelligence brings famous historical figures back to life to reflect on contemporary technology...
Learn more
Oxford Immune Algorithmics (OIA) Successfully Completes ISO 27001
Reading, March 10, 2024. Oxford Immune Algorithmics (OIA) is officially ISO/IEC 27001:2022 certified following a rigorous independent audit. This certification is a testament to our dedication to best practices in data security.
Learn more
Oxford Immune Algorithmics Signs Agreement with the Alan Turing Institute
Oxford Immune Algorithmics (OIA) has signed an agreement with The Alan Turing Institute (ATI) to advise the ATI on the adoption of AI across all sectors at the national level. In the agreement, our founder, Dr. Hector Zenil...
Learn more
A(G)I Definition, Safety, Regulation White Paper
This is our take on A(G)I Safety and Regulation from the perspective of and for smaller but highly innovative deep-tech players, from startups to SMEs.
Learn more
OIA Featured on the NHS 75th Anniversary Book, IFA, CogX and Bloomberg TV
The OIA team has been quite busy this quarter. First, we were invited to appear on the NHS 75th. Anniversary book in the context of the British Parliament History Project, and to the associated event at Westminster in London attended by Dr. Hector Zenil...
Learn more
OIA Maintains ISO 13485 (QMS Medical Devices) Certification with Zero Non-Conformities
Founder of Oxford Immune Algorithmics (OIA) participates in the 73rd Annual Scientific Meeting as one of the trustees of the British Society for Research on Ageing (BSRA) representing King's College London and OIA/Algocyte...
Learn more
OIA Welcomes New Strategic Investor Mark Stevenson & New Board Advisor Abel Archundia to Drive Growth & Innovation in AI-Powered Precision Medicine
We are excited to announce the addition of two new supporters and collaborators of the OIA team, each of whom brings a wealth of expertise and a track record of success in their respective fields. Both are colleagues of OIA’s Founder, Dr. Hector Zenil
Learn more
OIA and Algocyte to be Featured on Ted Danson’s Advancements TV show on Bloomberg TV and Amazon Prime Video
As recently announced by DMG Productions, an upcoming episode of Advancements with Ted Danson will focus on recent developments in scientific research, diagnostic solutions, and disease treatment for improved healthcare.
Learn more
Oxford Immune Algorithmics’ CEO participates at the Ferguson Summit with fellow founders and investors in Florida
Fellow CEOs and founders at the Ferguson Summit in Palm, Beach, FL. Dr. Zenil, CEO of Oxford Immune Algorithmics is on the right.
Learn more
Presenting Algocyte in the Metaverse at Arab Health 2024 — Second consecutive year at the global healthcare medical expo, Dubai
This week, we were delighted to participate in the first-ever “Demo Day in the Metaverse**” organised by the Abu Dhabi Department of Health (DoH) as part of the Arab Health | Global Healthcare Medical Expo in Dubai 2024. This
Learn more
Q&A with OIA’s Founder: Complexity Frontiers
Given there is so much discussion at the moment around the future of AI and what is required in order to deliver more sophisticated autonomous applications, this summary is designed to provide an overview of some of the principles behind OI
Learn more
Algocyte® Achieves CE Certification As A Medical Device
We are very excited to share the announcement that we have accomplished a major milestone getting Algocyte® certified under the European Commission medical device directive.
Learn more
Connecting With The Local Community In Reading
We were invited to introduce OIA and present our work on AI for healthcare at the Thames Valley Artificial Intelligence meetup organised by Barclays AI Frenzy and Innovation Catalyst, University of Reading.
Learn more
Further Validation Of OIA’s Methods & Algorithms
An application of our research in causal models in molecular biology has been published today in one of the finest journals in molecular biology, Nucleic Acids Research (Oxford).
Learn more
Great Evening On ‘AI In Healthcare’
Promoted and streamed online worldwide and to the Austin Vita offices in Germany and the U.S., as advertised locally in Reading’s giant screen at the train station, six speakers welcomed 80 attendants
Learn more
OIA, Algocyte & Covid-19
Oxford Immune Algorithmics (OIA), like almost every other company and organisation around the world is putting in place contingency plans to downsize operations…
Learn more
OIA At Turing Founders Turingfest In Edinburgh
We are heading to #TuringFest19 in Edinburgh this August. OIA has been invited to participate in the Turing Founders event where startups and new companies meet investors.
Learn more
OIA is attending GIANT, health Europe’s largest festival of health tech innovation
On the 15-16 October 2019, OIA is attending The Global Innovation and New Technology Health Event at the Chelsea Football Club Stadium in London where it is showcased the leading health tech startups from around the world.
Learn more
OIA Attending Intelligent Health UK 2020
Organised in partnership with the NHSx, Intelligent Health UK is the World’s Leading AI in Medicine Summit, 5 February 2020 | London | UK
Learn more
OIA Has Been Invited To Pitch At Bioseed 2020
OIA will be at the the early stage life sciences investment event to be held at Level39 in Canary Wharf, London, January 20, 2020.
Learn more
OIA Invited To Pitch Algocyte® At Sthlm Tech
According to the organisers, STHLM TECH is the largest startup event in Europe where every geek, hacker, entrepreneur, investor, and designer around Stockholm comes together under one roof.
Learn more
OIA Is a Gold Sponsor of Automata 2020
AUTOMATA 2020 will focus on the theory and applications that many of OIA’s own proprietary methods are based upon, on the deep connections of discrete dynamical systems complexity…
Learn more
OIA Is Accepted Into The ‘Cdl-recovery’ Programme In Atlanta, U.s. To Help The World Bounce Back
OIA has been accepted into the ‘CDL-recovery’ programme in Atlanta, U.S. with the purpose to explore the U.S. market and contribute to the world recovery during and after COVID-19.
Learn more
OIA Is Accepted Into The Spinlab’s Prestigious Accelerating Programme
SpinLab, one of the best-ranked accelerating programmes in Europe based in Leipzig, Germany, has selected a handful of startups out of hundreds of applications, including OIA, to be supported and introduced…
Learn more
OIA Is Nominated for the Best Start-up Medtech Award 2020 by Obn
OIA has been nominated to the OBN awards for the Best Start-up Medtech in the UK. The awards celebrate outstanding achievement throughout the life sciences industry.
Learn more
OIA, Key Partner In UK’s EPSRC Research Network, Awarded Grant To Explore The Future Of Blood Testing
Oxford Immune Algorithmics’ (OIA) continues to be acknowledged both internationally and in the U.K. The recent announcement of the award of…
Learn more
OIA Members Deliver Invited Talk On Oia’s Cutting-edge A.i. At Automata 2020
IA’s CTO Dr. Jürgen Riedel and Senior AI Researcher Dr. Santiago Hernández-Orozco delivered an invited technical talk at the international conference AUTOMATA 2020, the 26th International Workshop on Cellular…
Learn more
OIA Presenting Its Responsible AI Technology at the Predictive Analytics World Summit
Our CEO, Dr. Hector Zenil, will be delivering the opening Keynote at the Predictive Analytics World summit on May 11, 2020 originally planned to be held in Munich, Germany but now to be held online.
Learn more
OIA Sponsors & Exhibits At Intelligent Health UK In London
OIA will be exhibiting at one of the world’s leading summits on AI in medicine, Intelligent Health 2020 on 5 February 2020 at a prime venue, the ExCel, London, U.K. where we will be promoting Algocyte, our flagship product for end-to-end re
Learn more
OIA’s New Branch Office In Abu Dhabi, U.A.E.
Supported by HUB71, a new subsidiary of OIA, Immune Algorithmics Middle East Ltd, has officially started operations and opened an office in Abu Dhabi.
Learn more
Opening Of Our New AI-Powered Biomedical Lab In A Prime Location In Reading, UK
We have been growing at an exciting rate and we have moved offices three times already only this year. We have now opened our new AI-biomedical lab this month and we are already thinking of expanding it.
Learn more
Our New Paper Published In Iscience (Cell Press) Lays Out The Foundations Of Our Technology
To Better Deal With Causality In Molecular Biology & Immunology To Make A Real Impact In The Future Of Healthcare
Learn more
Oxford Immune Algorithmics & Austin Vita Invite You To ‘AI In Healthcare’
Oxford Immune Algorithmics & Austin Vita Invite You To ‘AI In Healthcare’
Learn more
Oxford Immune Algorithmics Announces Appointment of Dr. Corey Cutler, Medical Oncology Innovator to its Scientific Advisory Board
Oxford Immune Algorithmics is proud to announce the appointment of internationally recognised innovator, Dr. Corey Cutler, to its Scientific Advisory Board.
Learn more
Oxford Immune Algorithmics Announces Appointment of Mr. Tony Cambridge to its Scientific Advisory Board
Oxford Immune Algorithmics, growing by leaps and bounds, recently announced the appointment of Mr. Tony Cambridge to its Scientific Advisory Board.
Learn more
Oxford Immune Algorithmics Announces Appointment Of Pioneering Academic Dr. Jason Berman To Its Scientific Advisory Board
Oxford Immune Algorithmics’ trajectory as a Medtech and Biotech company continues to accelerate. The award-winning company recently announced the appointment of pioneering…
Learn more
Oxford Immune Algorithmics, Creators of the AI-driven Solution Algocyte, Features Star Trek’s Commander Riker in new Video.
Oxford Immune Algorithmics (OIA), the award-winning A.I. company that specialises in rapid at-home testing for immune health monitoring, and the creators of Algocyte, know something about legacy.
Learn more
Oxford Immune Algorithmics Expands And Accelerates By Graduating From German-based Spinlab Accelerator Program
Oxford Immune Algorithmics (OIA), creator of the Algocyte health-tech venture, has officially graduated from the Class No. 11 German-based SpinLab accelerator.
Learn more
Oxford Immune Algorithmics Graduates From Global Creative Destruction Lab Program
We are proud to announce that Oxford Immune Algorithmics (OIA), creator of Algocyte, is part of the Creative Destruction Lab-Toronto Health Diagnostics Stream’s 2020/21 graduating cohort…
Learn more
Oxford Immune Algorithmics Has a Spot at GITEX, the World’s Largest Technology Event in Dubai
Oxford Immune Algorithmics recently participated in the 41st GITEX Global event hosted at the Dubai World Trade Centre in Dubai, UAE.
Learn more
Oxford Immune Algorithmics Is Awarded a Grant to Explore Applications of Automata to Areas of Causation and Machine Intelligence
The FQXi catalyses, supports, and disseminates research on questions at the foundations of physics, particularly new frontiers and innovative ideas integral to a deep understanding of reality.
Learn more
Oxford Immune Algorithmics Is Chosen As One Of The 50 Most Promising Game-changers In The Thames Valley In The Uk
Oxford Immune Algorithmics (OIA) has been chosen one of 50 game-changers in the Thames Valley (UK’s Silicon Valley) for the creation of Algocyte and our responsible AI approaches…
Learn more
Oxford Immune Algorithmics Is Now a Cogx 2020 Sponsor With a Virtual Booth
OIA has become a sponsor and will join CogX 2020 as an exhibitor with a dedicated virtual booth. CogX is the Festival of AI and Emerging Technology and will take place on the 8th-10th June 2020.
Learn more
Oxford Immune Algorithmics is Part of the UAE and Hub71’s World Tour to #LondonTechWeek and #VivaTech in Paris.
This past week represented a significant one for Oxford Immune Algorithmics (OIA).
Learn more
Oxford Immune Algorithmics’ (OIA) AI-driven Solution Algocyte Featured on UK’s Open Access Media Portal on SARS-CoV-2 and Long Covid
We recently published an article on the U.K.’s Open Access Media portal entitled, ‘Could Immune Monitoring Be the Route to a Long-Covid Test?‘
Learn more
Oxford Immune Algorithmics’ (OIA) Algocyte, Voted one of Top 5 UK Precision Medicine Solutions
Oxford Immune Algorithmics (OIA)
Learn more
Oxford Immune Algorithmics (OIA) Appointed a Corporate Member of the Canadian College of Health Leaders.
The Canadian College of Health Leaders (CCLH) has announced the appointment of Oxford Immune Algorithmics (OIA) as a new corporate member of CCHL.
Learn more
Oxford Immune Algorithmics (OIA) Collaboration with the World’s First AI University MBZUAI
The mission of MBZUAI is to be the hub of fundamental AI research, training and transformation, and the global epicentre of research in the field. It is the world’s first university committed to AI, which makes the MBZUAI a perfect partner.
Learn more
Oxford Immune Algorithmics’ (OIA) Founder Invited to ‘Founder’s Forum’ Event during London’s Tech Week.
An exceptional experience was planned for a select group of tech Startup founders last week in London. The Founder’s Forum & Mubadala Capital Ventures hosted a special Founder’s Forum event celebrating London’s Tech Week.
Learn more
Oxford Immune Algorithmics (OIA) Partners With Myglobalhome To Revolutionise Healthcare In The Home
OIA’s flagship AI Medical Assistant, Algocyte, will be integrated into MyGlobalHome’s digital health ecosystem, allowing users to complete personal blood tests remotely at will…
Learn more
Oxford Immune Algorithmics (OIA) Secures A Coveted Spot In The UK Pavilion At The Dubai World Expo 2020
The UK’s Departament of International Trade recently announced the selection of Oxford Immune Algorithmics (OIA) as one of the health-tech companies that will participate in the UK’s Health Technology Showcase at Expo 2020.
Learn more
Oxford Immune Algorithmics Partners With The University Of Reading To Support Their Local Internship Scheme
Oxford Immune Algorithmics (OIA) is very proud to have partnered with the University of Reading and welcomes two of their students in Computer Science hired with the partial support of the University of Reading…
Learn more
Oxford Immune Algorithmics, Representing the UK as One of its Most Innovative Companies, Successfully Concludes Multiple Events in Dubai
Oxford Immune Algorithmics announced they are exhibiting at MWC/4YFN in Barcelona, February 28th – March 3rd.
Learn more
Oxford Immune Algorithmics Secures £5.1m To Advance Remote Health Monitoring And Precision Medicine
Drawing on more than a decade of research in computational biology and systems medicine conducted at institutions such as the the University of Oxford…
Learn more
Oxford Immune Algorithmics Wins International AI Competition To Predict Etihad’s Cash Flow Validating OIA’s AI Predictive Algorithms
Oxford Immune Algorithmics (OIA) has been announced the winner of Etihad’s AI international competition. Etihad Group Finance, owner of award-winning Abu Dhabi-based Etihad Airlines…
Learn more
Oxford University Innovation Sponsors The Planting Of A Tree In Wytham Woods In Honour Of OIA’s Launch
OIA’s first anniversary was this past September 25th and the University of Oxford planted a 4-year old beech tree in honour of Oxford Immune Algorithmics (OIA) at the Oxford University premises in Wytham…
Learn more
SFC And Kin Capital Join OIA As Investors With Joint Funds From The British Business Bank
We have successfully closed our latest funding round with SFC and KIN Capital leading it, award winning investors, both joining last week our multinational shareholder’s board supporting OIA.
Learn more
The Impact Of Covid19 On Patients With Chronic Diseases
Most global healthcare resources are focused on COVID19 and this is largely disrupting the continuum of care for patients with chronic diseases (Chudasama et al., 2020).
Learn more
Oxford Immune Algorithmics (OIA) Successfully Completes QMS ISO 13485
Oxford Immune Algorithmics (OIA), the creators of Algocyte, is delighted to announce it has successfully received ISO 13485 certification status from NQA.
Learn more
Why Use Algocyte?*
Algocyte is helping change how frequently and where people are monitored and get tested, but most people (89%) are still at high risk of infection from travelling…
Learn more
Mou Signing Ceremony Between Khawarizmi International College & Oxford Immune Algorithmics
Oxford Immune Algorithmics (OIA) is honoured to announce a new partnership with a major university in the UAE, Khawarizmi International College or KIC, made possible by Dr Assem Al-Hajj…
Learn more
Newly Published and Accepted Papers
Signed by Oxford Immune Algorithmics, these two new papers show how we are trying to transform healthcare with science technology.
Learn more
OIA Invited To The Global AI & Big Data World Expo In London, UK To Deliver A Talk On Causal Machine Learning In Healthcare
Invited by the organisers, Dr. Zenil (CEO) presented our research on AI for medicine at the World Expo on AI, Big Data & IoT at the Olympia Exhibition Centre on the 25th April in London, U.K.
Learn more
OIA Invited As Academic Partner To CogX In London, The Festival Of AI And Emergent Technologies
A three day festival of events on 10-12 June, 2019.
Learn more
OIA Manifesto To End All (Preventable) Human Diseases, Today!
At Oxford Immune Algorithmics (OIA) we firmly believe that it is our obligation to do our best to promote the use of the most advanced scientific and technological tools and methods currently available in the fight against human disease.
Learn more